We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Verisk (VRSK) Stock Rallies 30.5% Year to Date: Here's Why
Read MoreHide Full Article
Verisk Analytics, Inc.’s (VRSK - Free Report) shares have gained 30.5% of value in the year-to-date period compared with the industry’s 2% increase.
Reasons for Surge
Verisk continues to witness higher organic revenue growth on increase in new customers for existing solutions, cross-sale of its existing solutions to customers at present, and also the sale of new solutions. In the third quarter of 2020, revenues of $702.7 million beat the consensus estimate by 1.5% and increased 7.6% year over year on a reported basis and 3.6% on an organic constant-currency basis.
Acquisitions have been one of the key growth catalysts for Verisk. The company is continuously acquiring and making investments to expand its data and analytics capabilities across industries. The recent acquisition of Franco Signor strengthened the company’s foothold in the Medicare space.
Favorable Estimate Revisions & Positive Surprise
The Zacks Consensus Estimate for current-quarter earnings increased 4% to $1.31 per share in the past 60 days.
Moreover, Verisk has a trailing four-quarter earnings surprise of 5.5%, on average.
The long-term expected earnings per share (three to five years) growth rate for Gartner, Automatic Data Processing and Insperity is 13.5%, 12% and 15%, respectively.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Image: Bigstock
Verisk (VRSK) Stock Rallies 30.5% Year to Date: Here's Why
Verisk Analytics, Inc.’s (VRSK - Free Report) shares have gained 30.5% of value in the year-to-date period compared with the industry’s 2% increase.
Reasons for Surge
Verisk continues to witness higher organic revenue growth on increase in new customers for existing solutions, cross-sale of its existing solutions to customers at present, and also the sale of new solutions. In the third quarter of 2020, revenues of $702.7 million beat the consensus estimate by 1.5% and increased 7.6% year over year on a reported basis and 3.6% on an organic constant-currency basis.
Acquisitions have been one of the key growth catalysts for Verisk. The company is continuously acquiring and making investments to expand its data and analytics capabilities across industries. The recent acquisition of Franco Signor strengthened the company’s foothold in the Medicare space.
Favorable Estimate Revisions & Positive Surprise
The Zacks Consensus Estimate for current-quarter earnings increased 4% to $1.31 per share in the past 60 days.
Moreover, Verisk has a trailing four-quarter earnings surprise of 5.5%, on average.
Zacks Rank and Stocks to Consider
Verisk currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Business Services sector are Gartner, Inc. (IT - Free Report) , Automatic Data Processing (ADP - Free Report) and Insperity (NSP - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The long-term expected earnings per share (three to five years) growth rate for Gartner, Automatic Data Processing and Insperity is 13.5%, 12% and 15%, respectively.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>